Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications for weight loss are significantly transforming the fiel ...

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

She couldn’t afford the care she needed.

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of its phase III REGENCY trial of Gazyva®/Gazyvaro® (obinutuzumab) in people with active lupus nephritis (LN) was published ...

Indian scientists have developed a groundbreaking self-actuating drug delivery system for Rheumatoid Arthritis offering targeted relief with fewer side effects and longer-lasting results ...

The next God of War is potentially heading to Egypt, and these are the gods and goddesses we want to meet when we get there.

Manhattan officials are ready to begin a watermain extension and rehab of Well No. 7 into a state-of-the-art water treatment ...

Evan Y. Yu, MD, discusses the safety data from the phase 3 PEACE-3 study of enzalutamide (ENZA) combined with radium-223 ...

Evan Y. Yu, MD, discusses the key efficacy findings from the PEACE-3 study, which assessed the combination of enzalutamide (ENZA) and radium-223 (Ra-223) in androgen receptor pathway inhibitor ...